News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Surprise Might Spark Genentech, Inc. (DNA)


2/6/2008 7:15:52 AM

Take note of this important date for Genentech: Feb 23. That's when the Food and Drug Administration is expected to issue its approval decision on Avastin as a treatment for metastatic breast cancer. Read full article below.

Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES